TD Cowen Downgrades BioLife Solutions to Hold, Lowers Price Target to $31

Benzinga Newsdesk www.benzinga.com Negative 92.8%

Neg 92.8% Neu 0% Pos 0%

TD Cowen analyst Brendan Smith downgrades BioLife Solutions (NASDAQ:BLFS) from Buy to Hold and lowers the price target from $33 to $31.